{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:22:39Z","timestamp":1793107359373,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02774-6","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:01:46Z","timestamp":1784242906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A microbiome meta-transcriptomics pipeline identifies a neutrophil elastase inhibitor that protects the colonic epithelial barrier"],"prefix":"10.1038","volume":"11","author":[{"given":"Bojan","family":"Stojkovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs","family":"Bekkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake P.","family":"Violi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett A.","family":"Neilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan Hui","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1248-9590","authenticated-orcid":false,"given":"Simon","family":"Keely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Donald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Riveros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard E.","family":"Kaiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"2774_CR1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.jcmgh.2022.09.002","volume":"14","author":"L Kang","year":"2022","unstructured":"Kang, L. et al. Neutrophil-epithelial crosstalk during intestinal inflammation. Cell Mol. Gastroenterol. Hepatol. 14, 1257\u20131267 (2022).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"2774_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre, C., Honap, S. & Peyrin-Biroulet, L. Ulcerative colitis. Lancet 402, 571\u2013584 (2023).","journal-title":"Lancet"},{"key":"2774_CR3","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","volume":"389","author":"J Torres","year":"2017","unstructured":"Torres, J., Mehandru, S., Colombel, J. F. & Peyrin-Biroulet, L. Crohn\u2019s disease. Lancet 389, 1741\u20131755 (2017).","journal-title":"Lancet"},{"key":"2774_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12876-023-02675-w","volume":"23","author":"TH Gibble","year":"2023","unstructured":"Gibble, T. H. et al. Identification of inadequate responders to advanced therapy among commercially-insured adult patients with Crohn\u2019s disease and ulcerative colitis in the United States. BMC Gastroenterol. 23, 63 (2023).","journal-title":"BMC Gastroenterol."},{"key":"2774_CR5","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1038\/ctg.2015.63","volume":"7","author":"G Roda","year":"2016","unstructured":"Roda, G., Jharap, B., Neeraj, N. & Colombel, J. F. Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management. Clin. Transl. Gastroenterol. 7, e135 (2016).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"2774_CR6","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1053\/gast.2000.20231","volume":"119","author":"EJ Irvine","year":"2000","unstructured":"Irvine, E. J. & Marshall, J. K. Increased intestinal permeability precedes the onset of Crohn\u2019s disease in a subject with familial risk. Gastroenterology 119, 1740\u20131744 (2000).","journal-title":"Gastroenterology"},{"key":"2774_CR7","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1053\/j.gastro.2020.08.005","volume":"159","author":"W Turpin","year":"2020","unstructured":"Turpin, W. et al. Increased intestinal permeability is associated with later development of Crohn\u2019s disease. Gastroenterology 159, 2092\u20132100.e2095 (2020).","journal-title":"Gastroenterology"},{"key":"2774_CR8","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s00535-023-02013-7","volume":"58","author":"G Parkes","year":"2023","unstructured":"Parkes, G. et al. Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis. J. Gastroenterol. 58, 990\u20131002 (2023).","journal-title":"J. Gastroenterol."},{"key":"2774_CR9","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cgh.2016.01.015","volume":"14","author":"SC Shah","year":"2016","unstructured":"Shah, S. C., Colombel, J. F., Sands, B. E. & Narula, N. Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 14, 1245\u20131255.e1248 (2016).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2774_CR10","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1136\/gutjnl-2014-307477","volume":"64","author":"A Bressenot","year":"2015","unstructured":"Bressenot, A. et al. Comparing histological activity indexes in UC. Gut 64, 1412\u20131418 (2015).","journal-title":"Gut"},{"key":"2774_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41575-023-00871-3","volume":"21","author":"C Danne","year":"2024","unstructured":"Danne, C., Skerniskyte, J., Marteyn, B. & Sokol, H. Neutrophils: from IBD to the gut microbiota. Nat. Rev. Gastroenterol. Hepatol. 21, 184\u2013197 (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2774_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fcimb.2020.00021","volume":"10","author":"A Jablaoui","year":"2020","unstructured":"Jablaoui, A. et al. Fecal serine protease profiling in inflammatory bowel diseases. Front. Cell Infect. Microbiol. 10, 21 (2020).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"2774_CR13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41564-021-01050-3","volume":"7","author":"RH Mills","year":"2022","unstructured":"Mills, R. H. et al. Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity. Nat. Microbiol. 7, 262\u2013276 (2022).","journal-title":"Nat. Microbiol."},{"key":"2774_CR14","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1053\/j.gastro.2020.12.004","volume":"160","author":"HJ Galipeau","year":"2021","unstructured":"Galipeau, H. J. et al. Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis. Gastroenterology 160, 1532\u20131545 (2021).","journal-title":"Gastroenterology"},{"key":"2774_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/gut.2005.073817","volume":"55","author":"C Manichanh","year":"2006","unstructured":"Manichanh, C. et al. Reduced diversity of faecal microbiota in Crohn\u2019s disease revealed by a metagenomic approach. Gut 55, 205\u2013211 (2006).","journal-title":"Gut"},{"key":"2774_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/gut.2003.025403","volume":"53","author":"SJ Ott","year":"2004","unstructured":"Ott, S. J. et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53, 685\u2013693 (2004).","journal-title":"Gut"},{"key":"2774_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S2468-1253(21)00400-3","volume":"7","author":"C Haifer","year":"2022","unstructured":"Haifer, C. et al. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol. Hepatol. 7, 141\u2013151 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2774_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","volume":"149","author":"P Moayyedi","year":"2015","unstructured":"Moayyedi, P. et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149, 102\u2013109.e106 (2015).","journal-title":"Gastroenterology"},{"key":"2774_CR19","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","volume":"389","author":"S Paramsothy","year":"2017","unstructured":"Paramsothy, S. et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 389, 1218\u20131228 (2017).","journal-title":"Lancet"},{"key":"2774_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-41182-6","volume":"13","author":"J Feng","year":"2023","unstructured":"Feng, J. et al. Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis. Sci. Rep. 13, 14494 (2023).","journal-title":"Sci. Rep."},{"key":"2774_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1244293","volume":"14","author":"HK Krishnamurthy","year":"2023","unstructured":"Krishnamurthy, H. K. et al. Gut commensals and their metabolites in health and disease. Front Microbiol 14, 1244293 (2023).","journal-title":"Front Microbiol"},{"key":"2774_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00281-024-01012-x","volume":"46","author":"S Kim","year":"2024","unstructured":"Kim, S., Seo, S. U. & Kweon, M. N. Gut microbiota-derived metabolites tune host homeostasis fate. Semin Immunopathol. 46, 2 (2024).","journal-title":"Semin Immunopathol."},{"key":"2774_CR23","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.cell.2016.10.034","volume":"167","author":"GE Kaiko","year":"2016","unstructured":"Kaiko, G. E. et al. The colonic crypt protects stem cells from microbiota-derived metabolites. Cell 167, 1137 (2016).","journal-title":"Cell"},{"key":"2774_CR24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s00535-005-1768-8","volume":"41","author":"Y Morohoshi","year":"2006","unstructured":"Morohoshi, Y. et al. Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis. J. Gastroenterol. 41, 318\u2013324 (2006).","journal-title":"J. Gastroenterol."},{"key":"2774_CR25","doi-asserted-by":"publisher","first-page":"158ra144","DOI":"10.1126\/scitranslmed.3004212","volume":"4","author":"JP Motta","year":"2012","unstructured":"Motta, J. P. et al. Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci. Transl. Med. 4, 158ra144 (2012).","journal-title":"Sci. Transl. Med."},{"key":"2774_CR26","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41586-019-1238-8","volume":"569","author":"Integrative, H. M. P. R. N. C","year":"2019","unstructured":"Integrative, H. M. P. R. N. C The integrative human microbiome project. Nature 569, 641\u2013648 (2019).","journal-title":"Nature"},{"key":"2774_CR27","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655\u2013662 (2019).","journal-title":"Nature"},{"key":"2774_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.chom.2017.04.010","volume":"21","author":"AN Ananthakrishnan","year":"2017","unstructured":"Ananthakrishnan, A. N. et al. Gut microbiome function predicts response to anti-integrin biologic therapy in inflammatory bowel diseases. Cell Host Microbe 21, 603\u2013610.e603 (2017).","journal-title":"Cell Host Microbe"},{"key":"2774_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.598152","volume":"11","author":"RV Cortez","year":"2021","unstructured":"Cortez, R. V. et al. Gut microbiome of children and adolescents with primary sclerosing cholangitis in association with ulcerative colitis. Front. Immunol. 11, 598152 (2021).","journal-title":"Front. Immunol."},{"key":"2774_CR30","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","volume":"63","author":"K Machiels","year":"2014","unstructured":"Machiels, K. et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63, 1275\u20131283 (2014).","journal-title":"Gut"},{"key":"2774_CR31","doi-asserted-by":"publisher","first-page":"16731","DOI":"10.1073\/pnas.0804812105","volume":"105","author":"H Sokol","year":"2008","unstructured":"Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. 105, 16731\u201316736 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"2774_CR32","doi-asserted-by":"publisher","first-page":"8935","DOI":"10.1039\/C9CC03183A","volume":"55","author":"N Akermi","year":"2019","unstructured":"Akermi, N. et al. para-Sulphonato-calix[n]arene capped silver nanoparticles challenge the catalytic efficiency and the stability of a novel human gut serine protease inhibitor. Chem. Commun. 55, 8935\u20138938 (2019).","journal-title":"Chem. Commun."},{"key":"2774_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12934-016-0596-2","volume":"15","author":"H Mkaouar","year":"2016","unstructured":"Mkaouar, H. et al. Siropins, novel serine protease inhibitors from gut microbiota acting on human proteases involved in inflammatory bowel diseases. Micro. Cell Fact. 15, 201 (2016).","journal-title":"Micro. Cell Fact."},{"key":"2774_CR34","doi-asserted-by":"publisher","first-page":"17246","DOI":"10.1074\/jbc.M601678200","volume":"281","author":"D Ivanov","year":"2006","unstructured":"Ivanov, D. et al. A serpin from the gut bacterium Bifidobacterium longum inhibits eukaryotic elastase-like serine proteases. J. Biol. Chem. 281, 17246\u201317252 (2006).","journal-title":"J. Biol. Chem."},{"key":"2774_CR35","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"2774_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2012-13-9-r79","volume":"13","author":"XC Morgan","year":"2012","unstructured":"Morgan, X. C. et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13, 1\u201318 (2012).","journal-title":"Genome Biol."},{"key":"2774_CR37","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","volume":"15","author":"D Gevers","year":"2014","unstructured":"Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn\u2019s disease. Cell Host Microbe 15, 382\u2013392 (2014).","journal-title":"Cell Host Microbe"},{"key":"2774_CR38","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1093\/nar\/gkh885","volume":"32","author":"MY Galperin","year":"2004","unstructured":"Galperin, M. Y. & Koonin, E. V. \u2018Conserved hypothetical\u2019proteins: prioritization of targets for experimental study. Nucleic Acids Res. 32, 5452\u20135463 (2004).","journal-title":"Nucleic Acids Res."},{"key":"2774_CR39","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1101\/gr.10.4.398","volume":"10","author":"P Bork","year":"2000","unstructured":"Bork, P. Powers and pitfalls in sequence analysis: the 70% hurdle. Genome Res. 10, 398\u2013400 (2000).","journal-title":"Genome Res."},{"key":"2774_CR40","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.3390\/biomedicines11051408","volume":"11","author":"A Bohra","year":"2023","unstructured":"Bohra, A. et al. The utility of faecal calprotectin, lactoferrin and other faecal biomarkers in discriminating endoscopic activity in Crohn\u2019s disease: a systematic review and meta-analysis. Biomedicines 11, 1408 (2023).","journal-title":"Biomedicines"},{"key":"2774_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1572-0241.2007.01556.x","volume":"103","author":"J Langhorst","year":"2008","unstructured":"Langhorst, J. et al. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Off. J. Am. Coll. Gastroenterol. ACG 103, 162\u2013169 (2008).","journal-title":"Off. J. Am. Coll. Gastroenterol. ACG"},{"key":"2774_CR42","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1053\/j.gastro.2010.12.050","volume":"140","author":"JP Motta","year":"2011","unstructured":"Motta, J. P. et al. Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis. Gastroenterology 140, 1272\u20131282 (2011).","journal-title":"Gastroenterology"},{"key":"2774_CR43","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1172\/JCI29255","volume":"117","author":"N Cenac","year":"2007","unstructured":"Cenac, N. et al. Role for protease activity in visceral pain in irritable bowel syndrome. J. Clin. Investig. 117, 636\u2013647 (2007).","journal-title":"J. Clin. Investig."},{"key":"2774_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26282-y","volume":"8","author":"A Denadai-Souza","year":"2018","unstructured":"Denadai-Souza, A. et al. Functional proteomic profiling of secreted serine proteases in health and inflammatory bowel disease. Sci. Rep. 8, 7834 (2018).","journal-title":"Sci. Rep."},{"key":"2774_CR45","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41586-022-05181-3","volume":"609","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Identification of trypsin-degrading commensals in the large intestine. Nature 609, 582\u2013589 (2022).","journal-title":"Nature"},{"key":"2774_CR46","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000336995","volume":"30","author":"G Lakatos","year":"2012","unstructured":"Lakatos, G. et al. The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases. Dig. Dis. 30, 289\u2013295 (2012).","journal-title":"Dig. Dis."},{"key":"2774_CR47","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jcmgh.2018.05.008","volume":"6","author":"H Yoon","year":"2018","unstructured":"Yoon, H. et al. Increased pancreatic protease activity in response to antibiotics impairs gut barrier and triggers colitis. Cell. Mol. Gastroenterol. Hepatol. 6, 370\u2013388.e373 (2018).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"2774_CR48","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41385-021-00375-w","volume":"14","author":"JP Motta","year":"2021","unstructured":"Motta, J. P. et al. Epithelial production of elastase is increased in inflammatory bowel disease and causes mucosal inflammation. Mucosal Immunol. 14, 667\u2013678 (2021).","journal-title":"Mucosal Immunol."},{"key":"2774_CR49","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1053\/j.gastro.2011.05.035","volume":"141","author":"N Steck","year":"2011","unstructured":"Steck, N. et al. Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology 141, 959\u2013971 (2011).","journal-title":"Gastroenterology"},{"key":"2774_CR50","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0306-9877(02)00243-8","volume":"59","author":"XF Qin","year":"2002","unstructured":"Qin, X. F. Impaired inactivation of digestive proteases by deconjugated bilirubin: the possible mechanism for inflammatory bowel disease. Med Hypotheses 59, 159\u2013163 (2002).","journal-title":"Med Hypotheses"},{"key":"2774_CR51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cytogfr.2021.01.005","volume":"59","author":"S Nugteren","year":"2021","unstructured":"Nugteren, S. & Samsom, J. N. Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancer. Cytokine Growth Factor Rev. 59, 22\u201335 (2021).","journal-title":"Cytokine Growth Factor Rev."},{"key":"2774_CR52","doi-asserted-by":"publisher","first-page":"14791","DOI":"10.1016\/S0021-9258(18)77182-2","volume":"265","author":"O Wiedow","year":"1990","unstructured":"Wiedow, O., Schr\u00f6der, J., Gregory, H., Young, J. & Christophers, E. Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J. Biol. Chem. 265, 14791\u201314795 (1990).","journal-title":"J. Biol. Chem."},{"key":"2774_CR53","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1189\/jlb.0906581","volume":"81","author":"M Schmid","year":"2007","unstructured":"Schmid, M. et al. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn\u2019s disease. J. Leucoc. Biol. 81, 907\u2013915 (2007).","journal-title":"J. Leucoc. Biol."},{"key":"2774_CR54","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/gtc.12888","volume":"26","author":"S Ozaka","year":"2021","unstructured":"Ozaka, S. et al. Protease inhibitory activity of secretory leukocyte protease inhibitor ameliorates murine experimental colitis by protecting the intestinal epithelial barrier. Genes Cells 26, 807\u2013822 (2021).","journal-title":"Genes Cells"},{"key":"2774_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.682065","volume":"12","author":"H Van Spaendonk","year":"2021","unstructured":"Van Spaendonk, H. et al. The effect of a novel serine protease inhibitor on inflammation and intestinal permeability in a murine colitis transfer model. Front. Pharm. 12, 682065 (2021).","journal-title":"Front. Pharm."},{"key":"2774_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1580-7","volume":"10","author":"C Zhang","year":"2019","unstructured":"Zhang, C. et al. Inhibition of HtrA2 alleviated dextran sulfate sodium (DSS)-induced colitis by preventing necroptosis of intestinal epithelial cells. Cell Death Dis. 10, 344 (2019).","journal-title":"Cell Death Dis."},{"key":"2774_CR57","doi-asserted-by":"crossref","unstructured":"Mkaouar, H. et al. Gut serpinome: emerging evidence in IBD. Int. J. Mol. Sci. 22, 6088 (2021).","DOI":"10.3390\/ijms22116088"},{"key":"2774_CR58","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1007\/s00394-023-03237-2","volume":"62","author":"S Li","year":"2023","unstructured":"Li, S. et al. Regulation of gut microbiota and alleviation of DSS-induced colitis by vitexin. Eur. J. Nutr. 62, 3433\u20133445 (2023).","journal-title":"Eur. J. Nutr."},{"key":"2774_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.610946","volume":"7","author":"A Mikami","year":"2020","unstructured":"Mikami, A. et al. Oral Administration of flavonifractor plautii, a bacteria increased with green tea consumption, promotes recovery from acute colitis in mice via suppression of IL-17. Front. Nutr. 7, 610946 (2020).","journal-title":"Front. Nutr."},{"key":"2774_CR60","doi-asserted-by":"publisher","first-page":"e49646","DOI":"10.1371\/journal.pone.0049646","volume":"7","author":"N Gill","year":"2012","unstructured":"Gill, N. et al. Neutrophil elastase alters the murine gut microbiota resulting in enhanced Salmonella colonization. PLoS ONE 7, e49646 (2012).","journal-title":"PLoS ONE"},{"key":"2774_CR61","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/nmeth.3589","volume":"12","author":"DT Truong","year":"2015","unstructured":"Truong, D. T. et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat. Methods 12, 902\u2013903 (2015).","journal-title":"Nat. Methods"},{"key":"2774_CR62","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"2774_CR63","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","volume":"30","author":"T Seemann","year":"2014","unstructured":"Seemann, T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30, 2068\u20132069 (2014).","journal-title":"Bioinformatics"},{"key":"2774_CR64","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1748-7188-6-26","volume":"6","author":"R Lorenz","year":"2011","unstructured":"Lorenz, R. et al. ViennaRNA package 2.0. Algorithms Mol. Biol. 6, 26 (2011).","journal-title":"Algorithms Mol. Biol."},{"key":"2774_CR65","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1093\/bioinformatics\/bts565","volume":"28","author":"L Fu","year":"2012","unstructured":"Fu, L., Niu, B., Zhu, Z., Wu, S. & Li, W. CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics 28, 3150\u20133152 (2012).","journal-title":"Bioinformatics"},{"key":"2774_CR66","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkt214","volume":"41","author":"Y Liao","year":"2013","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 41, e108 (2013).","journal-title":"Nucleic Acids Res."},{"key":"2774_CR67","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","volume":"68","author":"CA Lamb","year":"2019","unstructured":"Lamb, C. A. et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 68, s1\u2013s106 (2019).","journal-title":"Gut"},{"key":"2774_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-016-1323-z","volume":"17","author":"GE Hoffman","year":"2016","unstructured":"Hoffman, G. E. & Schadt, E. E. variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinform. 17, 483 (2016).","journal-title":"BMC Bioinform."},{"key":"2774_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"2774_CR70","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"2774_CR71","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41587-019-0036-z","volume":"37","author":"JJ Almagro Armenteros","year":"2019","unstructured":"Almagro Armenteros, J. J. et al. SignalP 5.0 improves signal peptide predictions using deep neural networks. Nat. Biotechnol. 37, 420\u2013423 (2019).","journal-title":"Nat. Biotechnol."},{"key":"2774_CR72","doi-asserted-by":"publisher","first-page":"D669","DOI":"10.1093\/nar\/gkv1269","volume":"44","author":"V Eichinger","year":"2016","unstructured":"Eichinger, V. et al. EffectiveDB-updates and novel features for a better annotation of bacterial secreted proteins and Type III, IV, VI secretion systems. Nucleic Acids Res. 44, D669\u2013D674 (2016).","journal-title":"Nucleic Acids Res."},{"key":"2774_CR73","doi-asserted-by":"publisher","first-page":"14716","DOI":"10.1021\/jacs.3c02655","volume":"145","author":"X Huang","year":"2023","unstructured":"Huang, X. et al. Oligomeric remodeling by molecular glues revealed using native mass spectrometry and mass photometry. J. Am. Chem. Soc. 145, 14716\u201314726 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"2774_CR74","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell Proteom. 13, 2513\u20132526 (2014).","journal-title":"Mol. Cell Proteom."},{"key":"2774_CR75","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-4939-9631-5_5","volume":"2029","author":"J Bruce","year":"2019","unstructured":"Bruce, J., Kaiko, G. E. & Keely, S. Isolation and in vitro culture of human gut progenitor cells. Methods Mol. Biol. 2029, 49\u201362 (2019).","journal-title":"Methods Mol. Biol."},{"key":"2774_CR76","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1126\/science.1223821","volume":"338","author":"H Miyoshi","year":"2012","unstructured":"Miyoshi, H., Ajima, R., Luo, C. T., Yamaguchi, T. P. & Stappenbeck, T. S. Wnt5a potentiates TGF-beta signaling to promote colonic crypt regeneration after tissue injury. Science 338, 108\u2013113 (2012).","journal-title":"Science"},{"key":"2774_CR77","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1038\/nprot.2013.153","volume":"8","author":"H Miyoshi","year":"2013","unstructured":"Miyoshi, H. & Stappenbeck, T. S. In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture. Nat. Protoc. 8, 2471\u20132482 (2013).","journal-title":"Nat. Protoc."},{"key":"2774_CR78","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1136\/gutjnl-2013-306651","volume":"64","author":"KL VanDussen","year":"2015","unstructured":"VanDussen, K. L. et al. Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut 64, 911\u2013920 (2015).","journal-title":"Gut"},{"key":"2774_CR79","doi-asserted-by":"crossref","unstructured":"Kaiko, G. E. et al. PAI-1 augments mucosal damage in colitis. Sci. Transl. Med. 11, eaat0852 (2019).","DOI":"10.1126\/scitranslmed.aat0852"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02774-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02774-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02774-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:01:47Z","timestamp":1784242907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02774-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2774"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02774-6","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.B., B.S. and G.K. are inventors on provisional patent applications for the use of BMG-1. SK reports consultancy and positions held on advisory boards for: Gossamer Bio [Scientific Advisory Board], Anatara Lifescience [Scientific Advisory Board], Microba Life Science [consultancy], and Immuron [consultancy] unrelated to this work.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"279"}}